Profil
John Adams is the founder of Corhepta Pharmaceuticals, Inc. Dr. Adams is the Chief Scientific Officer at Inhibikase Therapeutics, Inc. since 2025.
Former jobs include Head-Research at Arena Pharmaceuticals, Inc., Senior Vice President-Translational Science at Reneo Pharmaceuticals, Inc., and Senior Vice President-Discovery Biology at Iambic Therapeutics, Inc. Education includes a doctorate from the University of California, Los Angeles and an undergraduate degree from the University of California, Santa Barbara.
Aktive Positionen von John Adams
| Unternehmen | Position | Beginn |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 24.02.2025 |
Ehemalige bekannte Positionen von John Adams
| Unternehmen | Position | Ende |
|---|---|---|
| ARENA PHARMACEUTICALS | Technik-/Wissenschafts-/F&E-Leiter | - |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Corporate Officer/Principal | - |
| ONKURE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von John Adams
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases | Health Technology |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Technology Services |
















